[HTML][HTML] Thoracic involvement in IgG4-related disease in a UK-based patient cohort

JP Corcoran, EL Culver, RM Anstey, A Talwar… - Respiratory …, 2017 - Elsevier
IgG4-related disease (IgG4-RD) is a multi-system fibro-inflammatory disorder with classical
histopathological findings, often in the context of elevated serum IgG4 levels. The thoracic …

[HTML][HTML] Screening success: A virtual MDT can reduce the number of patients requiring respiratory follow-up post-COVID-19 pneumonia in line with British Thoracic …

R Anstey, J Rossdale, A Dereham, E Peter… - Clinical …, 2022 - ncbi.nlm.nih.gov
Methods We reviewed all patients with a clinico-radiological diagnosis of COVID-19 admitted
to hospital during a 3-month period and assigned a follow-up stream based on British …

EPIDEMIC EBOLA

PC Matthews, S Lumley, R Anstey, A Esara… - 2015 - researchgate.net
• Since the beginning of 2014, there has been a large outbreak of Viral Haemorrhagic Fever
(VHF) casued by Ebola Virus Disease (EVD) with its epicentre in three countries in West …

Awareness, knowledge, and attitudes toward screening and treatment of masked hypertension in primary care

…, C Alcántara, T Valadares, DE Anstey… - American Journal of …, 2021 - academic.oup.com
Background Hypertension guidelines recommend screening and treatment for masked
hypertension (MHT). Yet, few primary care providers (PCPs) screen for MHT, and little is known …

[HTML][HTML] AJPH Peer Reviewers: Thank You for Your Services

B Selzer, M Henry, K Poe… - American Journal of …, 2022 - ajph.aphapublications.org
Correspondence should be sent to Brian Selzer, American Public Health Association, 800 I
St, NW, Washington, DC 20001 (e-mail: brian.[email protected] org). Reprints can be ordered …

[HTML][HTML] Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

RECOVERY Collaborative Group - Lancet (London, England), 2022 - ncbi.nlm.nih.gov
Background Aspirin has been proposed as a treatment for COVID-19 on the basis of its anti-thrombotic
properties. We aimed to evaluate the efficacy and safety of aspirin in patients …

Renin-angiotensin system modulation with synthetic angiotensin (1-7) and angiotensin II type 1 receptor–biased ligand in adults with COVID-19: two randomized …

WH Self, MS Shotwell, KW Gibbs, M De Wit, DC Files… - Jama, 2023 - jamanetwork.com
Importance Preclinical models suggest dysregulation of the renin-angiotensin system (RAS)
caused by SARS-CoV-2 infection may increase the relative activity of angiotensin II …

Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial

S Florescu, D Stanciu, M Zaharia, A Kosa, D Codreanu… - JAMA, 2022 - jamanetwork.com
Importance The efficacy of antiplatelet therapy in critically ill patients with COVID-19 is uncertain.
Objective To determine whether antiplatelet therapy improves outcomes for critically ill …

[HTML][HTML] Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised …

RECOVERY Collaborative Group - Lancet (London, England), 2023 - ncbi.nlm.nih.gov
Background Low-dose corticosteroids have been shown to reduce mortality for patients with
COVID-19 requiring oxygen or ventilatory support (non-invasive mechanical ventilation, …

[HTML][HTML] Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

RECOVERY Collaborative Group - Lancet (London, England), 2021 - ncbi.nlm.nih.gov
Background In this study, we aimed to evaluate the effects of tocilizumab in adult patients
admitted to hospital with COVID-19 with both hypoxia and systemic inflammation. Methods This …